Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a significant therapeutic option for managing type 2 diabetes and obesity. Its role in improving glycemic control and facilitating weight loss has been well-documented. However, understanding the long-term safety …

